Literature DB >> 18560907

Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12.

D A Power1, J P Burton, C N Chilcott, P J Dawes, J R Tagg.   

Abstract

A powder preparation of the oral probiotic Streptococcus salivarius K12 has been given to 19 young otitis media-prone children following a 3-day course of amoxicillin administered as a preliminary to ventilation tube placement. In two subjects, the use of strain K12 appeared to effect the expansion of an indigenous population of inhibitory S. salivarius. In other children, strain K12 colonisation extended beyond the oral cavity to also include the nasopharynx or adenoid tissue. The relatively low proportion (33%) of subjects that colonised was attributed to failure of the amoxicillin pre-treatment to sufficiently reduce the indigenous S. salivarius populations prior to dosing with strain K12 powder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560907     DOI: 10.1007/s10096-008-0569-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  Use of repetitive (repetitive extragenic palindromic and enterobacterial repetitive intergeneric consensus) sequences and the polymerase chain reaction to fingerprint the genomes of Rhizobium meliloti isolates and other soil bacteria.

Authors:  F J de Bruijn
Journal:  Appl Environ Microbiol       Date:  1992-07       Impact factor: 4.792

2.  Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.

Authors:  Philip A Wescombe; Jeremy P Burton; Peter A Cadieux; Nikolai A Klesse; Otto Hyink; Nicholas C K Heng; Chris N Chilcott; Gregor Reid; John R Tagg
Journal:  Antonie Van Leeuwenhoek       Date:  2006-07-27       Impact factor: 2.271

3.  Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial.

Authors:  K Roos; E G Håkansson; S Holm
Journal:  BMJ       Date:  2001-01-27

4.  The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue.

Authors:  Karen P Dierksen; Chris J Moore; Megan Inglis; Philip A Wescombe; John R Tagg
Journal:  FEMS Microbiol Ecol       Date:  2006-10-27       Impact factor: 4.194

5.  Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.

Authors:  Otto Hyink; Philip A Wescombe; Mathew Upton; Nancy Ragland; Jeremy P Burton; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2006-12-28       Impact factor: 4.792

6.  Safety assessment of the oral cavity probiotic Streptococcus salivarius K12.

Authors:  Jeremy P Burton; Philip A Wescombe; Chris J Moore; Chris N Chilcott; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

7.  Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis--a randomized placebo-controlled multicentre study.

Authors:  K Roos; S E Holm; E Grahn-Håkansson; L Lagergren
Journal:  Scand J Infect Dis       Date:  1996

8.  Identity of viridans streptococci isolated from cases of infective endocarditis.

Authors:  C W Douglas; J Heath; K K Hampton; F E Preston
Journal:  J Med Microbiol       Date:  1993-09       Impact factor: 2.472

9.  Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius.

Authors:  J R Tagg; V Pybus; L V Phillips; T M Fiddes
Journal:  Arch Oral Biol       Date:  1983       Impact factor: 2.633

10.  Otitis media and speech and language: a meta-analysis of prospective studies.

Authors:  Joanne E Roberts; Richard M Rosenfeld; Susan A Zeisel
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

  10 in total
  24 in total

1.  Something Old and Something New: An Update on the Amazing Repertoire of Bacteriocins Produced by Streptococcus salivarius.

Authors:  Philip A Wescombe; Nicholas C K Heng; Jeremy P Burton; John R Tagg
Journal:  Probiotics Antimicrob Proteins       Date:  2010-03       Impact factor: 4.609

2.  Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.

Authors:  John Robert Tagg
Journal:  Probiotics Antimicrob Proteins       Date:  2009-02-21       Impact factor: 4.609

Review 3.  Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.

Authors:  Katarina Zupancic; Valentina Kriksic; Irena Kovacevic; Dujo Kovacevic
Journal:  Probiotics Antimicrob Proteins       Date:  2017-06       Impact factor: 4.609

4.  Oral bacteria as potential probiotics for the pharyngeal mucosa.

Authors:  Simone Guglielmetti; Valentina Taverniti; Mario Minuzzo; Stefania Arioli; Milda Stuknyte; Matti Karp; Diego Mora
Journal:  Appl Environ Microbiol       Date:  2010-04-23       Impact factor: 4.792

5.  Oropharyngeal Probiotic ENT-K12 as an Effective Dietary Intervention for Children With Recurrent Respiratory Tract Infections During Cold Season.

Authors:  Hongyan Guo; Xiaochen Xiang; Xuan Lin; Qiang Wang; Si Qin; Xinyan Lu; Jiawei Xu; Ying Fang; Yang Liu; Jing Cui; Zhi Li
Journal:  Front Nutr       Date:  2022-05-10

6.  Genome sequence of the lantibiotic bacteriocin producer Streptococcus salivarius strain K12.

Authors:  Caroline Barretto; Pablo Alvarez-Martin; Francis Foata; Pierre Renault; Bernard Berger
Journal:  J Bacteriol       Date:  2012-11       Impact factor: 3.490

Review 7.  Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease?

Authors:  M John; E M Dunne; P V Licciardi; C Satzke; O Wijburg; R M Robins-Browne; S O'Leary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-20       Impact factor: 3.267

8.  Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome.

Authors:  Paul V Licciardi; Zheng Quan Toh; Eileen Dunne; Sook-San Wong; Edward K Mulholland; Mimi Tang; Roy M Robins-Browne; Catherine Satzke
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

9.  Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media.

Authors:  Francesco Di Pierro; Guido Donato; Federico Fomia; Teresa Adami; Domenico Careddu; Claudia Cassandro; Roberto Albera
Journal:  Int J Gen Med       Date:  2012-11-30

10.  Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12.

Authors:  Gemma L Laws; John D F Hale; Roslyn A Kemp
Journal:  Probiotics Antimicrob Proteins       Date:  2021-07-19       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.